儿童急性淋巴细胞白血病中CDKN2A/2B删除的预后影响:系统性审查和元分析
Sanjana Sarangarajan1, Jagdish Prasad Meena1, Aditya Kumar Gupta1
1Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Leukemia & lymphoma
|June 25, 2025
概括
循环素依赖性激酶2A/2B (CDKN2A/2B) 的删除显著恶化了儿科急性淋巴细胞白血病 (ALL) 的存活率. 这种基因变异与ALL患者治疗反应不佳和复发率较高有关.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 儿科血液学 儿科血液学
背景情况:
- 儿科急性淋巴细胞白血病 (ALL) 是一种常见的儿童癌症.
- 准确的预后标记对于ALL有效的风险分层和治疗规划至关重要.
- 特定遗传变化的作用,如循环林依赖激酶2A/2B (CDKN2A/2B) 删除,在ALL结局中需要进一步评估.
研究的目的:
- 评估循环素依赖性激酶2A/2B (CDKN2A/2B) 删除对儿科急性淋巴细胞白血病 (ALL) 的生存结果的影响.
- 评估CDKN2A/2B删除与治疗反应之间的关联,包括普得尼索隆敏感性和复发率.
主要方法:
- 对已发表的研究进行了系统审查和元分析.
- 使用随机效应模型将危险比率 (HRs) 和风险比率 (RRs) 汇总起来.
- 从14项研究 (n=2532) 的生存曲线中提取了个体患者数据 (IPD),用于组合HR估计.
主要成果:
- 在研究和IPD水平上,CDKN2A/2B删除与缺乏无事件,无疾病和无复发的生存率显著相关.
- 较低的整体存活率也与IPD层面的CDKN2A/2B删除有关.
- 删除与较高风险的prednisolone反应较差,并增加复发率相关.
结论:
- CDKN2A/2B删除是儿科ALL的一个显著的负预后因素.
- 这些遗传变化会对疾病结果和治疗反应产生负面影响.
- 将CDKN2A/2B删除状态纳入风险分层可以提高儿童ALL的治疗策略.
相关概念视频
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458


